Middle Branch Partners has entered the market with an investment opportunity for a retained client who has an infection control durable medical equipment (DME) device for final commercialization. It addresses what is today a $20 billion dollar market growing at a CAGR of 6.6%. If you are interested in learning more, please contact Larry Barr or Chuck Weikel in the US or Göran Brorsson in Europe. Institutional investors only please.
